Literature DB >> 191454

Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X1, LP-X2, and LP-X3.

J R Patsch, K C Aune, A M Gotto, J D Morrisett.   

Abstract

Three different but related abnormal lipoprotein species, LP-X1, LP-X2, and LP-X3, have been isolated from cholestatic plasma by ethanol precipitation and zonal ultracentrifugation. All three populations are rich in phospholipids (64.9 to 67.5%) and cholesterol (23.0 to 26.8%) but poor in cholesteryl esters (0.4 to 1.9%), triglycerides (1.8 to 3.2%), and protein (3.2 to 6.7%) with differences in chemical composition which result in buoyant densities (1.038, 1.049, and 1.058, respectively) to allow their separation. LP-X1, LP-X2, and LP-X3 exhibited apparent flotation rates of 17.3, 9.7, and 3.2 Svedbergs and Stokes radii of 339, 343, and 294 A, respectively. As determined from circular dichroic measurements, the protein constituents of all three particles possessed a high degree of alpha helical structure (41 to 65%). Each LP-X particle exhibited abnormally low fluidity as evaluated by electron paramagnetic resonance. All of the particles contained human serum albumin and the C-proteins as major protein constituents, but only LP-X2 and LP-X3 contained apolipoprotein A-I and apolipoprotein E.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191454

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Effect of lipoprotein-X on lipid metabolism in rat kidney.

Authors:  K O; M Ly; D Z Fang; J Frohlich; P C Choy
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

2.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Alterations in levels of apolipoprotein C-III and C-II/C-III ratios in patients with liver disease.

Authors:  S Koga; K Yamamoto; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1984-02

4.  Effect of repeated apoA-IMilano/POPC infusion on lipids, (apo)lipoproteins, and serum cholesterol efflux capacity in cynomolgus monkeys.

Authors:  Herman J Kempen; Monica Gomaraschi; S Eralp Bellibas; Stephanie Plassmann; Brad Zerler; Heidi L Collins; Steven J Adelman; Laura Calabresi; Peter L J Wijngaard
Journal:  J Lipid Res       Date:  2013-07-04       Impact factor: 5.922

5.  Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate.

Authors:  E Griffin; W C Breckenridge; A Kuksis; M H Bryan; A Angel
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

6.  Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.

Authors:  A K Walli; D Seidel
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  Polyunsaturated fatty acid relatively decreases cholesterol content in THP-1 macrophage-derived foam cell: partly correlates with expression profile of CIDE and PAT members.

Authors:  Yue Song; Li-Jun Zhang; Hang Li; Yu Gu; Fan-Fan Li; Li-Na Jiang; Fang Liu; Jing Ye; Qing Li
Journal:  Lipids Health Dis       Date:  2013-07-23       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.